Association Between C-Reactive Protein and Age-Related Macular Degeneration
Top Cited Papers
- 11 February 2004
- journal article
- clinical trial
- Published by American Medical Association (AMA) in JAMA
- Vol. 291 (6) , 704-710
- https://doi.org/10.1001/jama.291.6.704
Abstract
Research from JAMA — Association Between C-Reactive Protein and Age-Related Macular Degeneration — ContextC-reactive protein (CRP) is a systemic inflammatory marker associated with risk for cardiovascular disease (CVD). Some risk factors for CVD are associated with age-related macular degeneration (AMD), but the association between CRP and AMD is unknown.ObjectiveTo test the hypothesis that elevated CRP levels are associated with an increased risk for AMD.Design, Setting, and ParticipantsA total of 930 (91%) of 1026 participants at 2 centers in the Age-Related Eye Disease Study (AREDS), a multicenter randomized trial of antioxidant vitamins and minerals, were enrolled in this case-control study. There were 183 individuals without any maculopathy, 200 with mild maculopathy, 325 with intermediate disease, and 222 with advanced AMD (geographic atrophy or neovascular AMD). The AMD status was assessed by standardized grading of fundus photographs, and stored fasting blood specimens drawn between January 1996 and April 1997 were analyzed for high-sensitivity CRP levels.Main Outcome MeasureAssociation between CRP and AMD.ResultsThe CRP levels were significantly higher among participants with advanced AMD (case patients) than among those with no AMD (controls; median values, 3.4 vs 2.7 mg/L; P = .02). After adjustment for age, sex, and other variables, including smoking and body mass index, CRP levels were significantly associated with the presence of intermediate and advanced stages of AMD. The odds ratio (OR) for the highest vs the lowest quartile of CRP was 1.65 (95% confidence interval [CI], 1.07-2.55; P for trend = .02). The OR for CRP values at or above the 90th percentile (10.6 mg/L) was 1.92 (95% CI, 1.20-3.06), and the OR for CRP values at or above the mean plus 2 SDs (16.8 mg/L) was 2.03 (95% CI, 1.03-4.00). A trend for an increased risk for intermediate and advanced AMD with higher levels of CRP was seen for smokers (OR, 2.16; 95% CI, 1.33-3.49) and those who never smoked (OR, 2.03; 95% CI, 1.19-3.46) with the highest level of CRP.ConclusionOur results suggest that elevated CRP level is an independent risk factor for AMD and may implicate the role of inflammation in the pathogenesis of AMD.Keywords
This publication has 10 references indexed in Scilit:
- An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient miceNature Medicine, 2003
- Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and PreventionCirculation, 2003
- Early age-related maculopathy in the cardiovascular health studyOphthalmology, 2003
- A role for local inflammation in the formation of drusen in the aging eyeAmerican Journal of Ophthalmology, 2002
- Novel risk factors for systemic atherosclerosis. A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein (a), and standard cholesterol screening as predictors of peripheral arterial diseaseACC Current Journal Review, 2001
- Dietary Fat and Risk for Advanced Age-Related Macular DegenerationArchives of Ophthalmology (1950), 2001
- Prospective study of dietary fat and the risk of age-related macular degenerationThe American Journal of Clinical Nutrition, 2001
- Elevated C-Reactive Protein Levels in Overweight and Obese AdultsJAMA, 1999
- Do age-related macular degeneration and cardiovascular disease share common antecedents?Ophthalmic Epidemiology, 1999
- Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study GroupPublished by American Medical Association (AMA) ,1994